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Background: Maternal morbidity estimations are not based on well-documented methodologies and thus have
limited validity for informing efforts to address the issue and improve maternal health. To fill this gap, maternal
morbidity needs to be clearly defined, driving the development of tools and indicators to measure and monitor
maternal health. This article describes the scoping exercise conducted by the World Health Organization’s
Department of Reproductive of Health and Research (WHO/RHR), as an essential first step in this process.
Methods: A literature review was conducted to identify the range of definitions and conditions included in various
studies of maternal morbidity with a special focus on the similarities and discrepancies of the definitions used
across the studies. Furthermore a questionnaire was developed which included sections on key areas identified
during the review and was sent out electronically to 130 international experts in the field of maternal health.
Results: Maternal morbidities have been categorized in a variety of ways based on the causes, types of
complications, and/or timeline. Issues regarding the time frame, severity, identification and classification and
demographics were identified as key areas in the literature that require further investigation to achieve consensus
on a maternal morbidity definition. Fifty-five (N = 55) individuals responded with completed questionnaires.
Respondents’ views on the time frame for the postpartum period varied from 6 weeks to beyond one year
postpartum, it was noted that time frame depended on the type of complication. The majority of respondents said
maternal morbidity should comprise a continuum of severity, whereas the identification of the cases should use a
mixed criteria employing multiple methods.
Conclusions: Significant discrepancy in literature and expert opinion exists concerning elements of a maternal
morbidity definition. There is a clear need for a concrete definition that would allow for consistent measurement
and monitoring of maternal morbidity across settings and time.Background
Improving maternal health and reducing related mortality
have been key concerns of the international community,
especially as one of the eight Millennium Development
Goals (MDG 5). However, to fully pursue MDG 5 and the
goal of improving maternal health, it is important to
broaden a focus to the entire spectrum of maternal mor-
bidity, beyond maternal mortality. Complications of preg-
nancy, childbirth, and the postpartum period may lead to
death or cause a continuum of morbidities that affect a
woman’s health for short or long-term periods during and
after pregnancy, and even throughout her life.* Correspondence: rachel.vanderkruik@gmail.com
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distribution, and reproduction in any mediumCommunity-based studies conducted in various coun-
tries have reported that women suffer significant mor-
bidity both during pregnancy and in the postnatal period
[1-4]. Such morbidities are also associated with poor
fetal and newborn outcomes. Maternal morbidity is
referred to as the base of the iceberg where maternal
deaths are only the tip [5], and it has been suggested
that for each maternal death, 20 or 30 women suffer
from morbidity [6,7]. However, these calculations are
not based on standard, well documented and transparent
methodologies, thus have limited usefulness and validity
for informing efforts to address the challenge of mater-
nal morbidity.
Maternal mortality and maternal near miss have been
defined by the World Health Organization, and there is
a growing body of evidence from low and high resourcentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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However, currently there is a lack of an agreed-upon
definition for maternal morbidity. Existing work on
maternal morbidity include an array of conditions, both
short- and long-term in varying combinations [8-11].
Three major issues have limited valid, routine, and
comparable measurements of maternal morbidity to
date. These are: the lack of a common definition and
identification criteria for maternal morbidity, lack of
standardized assessment tools especially at community
or primary health care level, and lack of common indica-
tors to measure morbidity. To accurately monitor the
improvement of maternal health, a definition for mater-
nal morbidity is first needed, which will then drive
development of tools and classifications to measure and
monitor complete maternal health. The World Health
Organization’s Department of Reproductive Health and
Research (WHO/RHR) has convened a Maternal Morbid-
ity Working Group that has embarked on a new project
to improve the scientific basis for defining, estimating,
and monitoring the magnitude of maternal morbidity [12].
The purpose of this project is to develop: a common
definition and identification criteria for maternal mor-
bidity that will then be used to provide estimates of the
magnitude of maternal morbidity, a validated assessment
tool for measuring maternal morbidity at community and
primary health care levels, and a set of indicators of
maternal morbidity measurement for program monitoring
and evaluation purposes.
The aim of this manuscript is to describe the scoping
exercise which was conducted as a first step in this
project. There were three key objectives to the scoping
exercise: 1) to explore how maternal morbidity is cur-
rently defined in the literature, 2) identify where there
are discrepancies and gaps in current research, and 3) to
determine the value of undertaking full systematic
reviews relevant to maternal morbidity concepts. The
scoping exercise had two components: 1) a literature
review on maternal morbidity definitions and 2) the
development and distribution of a questionnaire that
was sent to experts in maternal health around the world.
A scoping study can be used to rapidly map the key
concepts underlying a research area that has not been
comprehensively reviewed before [13], and the findings
of this scoping exercise are being used to inform future
work in the broader maternal morbidity project.
Methods
From June through August 2011, a literature review was
performed to identify and synthesize the range and type
of conditions included in the literature published in
English over the past 20 years on maternal morbidity. Our
research questions were: how is maternal morbidity defi-
ned in existing literature, what conditions are included indefinitions of maternal morbidity, and how are such
conditions classified and identified? The key words for our
literature review search included the following: maternal
morbidity, maternal complications, obstetric complica-
tions, obstetric morbidity, postpartum morbidity, perinatal
morbidity, and pregnancy complications. We searched
through PubMed, WHO electronic databases (Index Med-
icus for the Eastern Mediterranean Region, African Index
Medicus, Western Pacific Region Index Medicus), WHO
Reproductive Health Library as well as GoogleScholar.
We used a charting approach to synthesize and inter-
pret the data collected from the literature review. This
technique involved the creation of a ‘data charting form’
using the database programme Excel where information
about the studies and outcomes were recorded and orga-
nized according to key issues and themes relevant to
maternal morbidity [14]. Attention was paid to the
similarities and discrepancies of the maternal morbidity
definitions across the studies. This charting of key
themes from the literature identified discrepancies in 1)
the timeframe within which a maternal morbidity occurs,
2) the severity of conditions considered to be a maternal
morbidity 3) the way in which maternal morbidities are
classified, and 4) the ways in which maternal morbidities
are identified. The emergence of these themes supported
the development of the scoping exercise questionnaire.
The questionnaire was created for the purpose of asses-
sing expert opinion on the identified gaps in research
regarding maternal morbidity, and included questions on
the timeframe, severity, identification, and classification of
maternal morbidity (see Additional file 1).
A modified Delphi method was used among ten iden-
tified reproductive and maternal health experts within
the WHO headquarters in Geneva, Switzerland to revise
and finalize the questions within the questionnaire
[15,16]. The questionnaire was pilot tested by the identi-
fied health experts within WHO, who provided feedback
on the content and phrasing of the questions. There
were two rounds of review based on this modified
Delphi methodology. The finalized questionnaire was
then sent out electronically to 130 experts in the field of
maternal and reproductive health across all 6 WHO
geographic regions in October 2011. These experts were
identified from the distribution lists of WHO Reproduct-
ive Health and Research Department’s relevant products
and collaborators in related WHO working groups,
technical advisory groups and maternal focal points, as
identified by countries participating in country consulta-
tions for maternal mortality [17].
Implied consent was obtained as the questionnaire data
were collected using an optional online questionnaire tool
which gathers data anonymously. This paper describes the
results of an anonymous Delphi-like survey, requesting
professional expertise on technical matters. Questions of
Vanderkruik et al. BMC Pregnancy and Childbirth 2013, 13:213 Page 3 of 7
http://www.biomedcentral.com/1471-2393/13/213personal and sensitive nature were not part of the survey.
These are not considered research participant studies, and
are thus considered exempt from review board approvals.
The quantitative portions of the questionnaire were ana-
lyzed using descriptive statistics and measures of central
tendency. Themes were derived from this scoping exercise
using a thematic analysis of the qualitative data gathered
from open-ended questions in the survey. The themes
identified in the literature review and charting approach
described above guided the thematic analysis of qualitative
data collected.
Results
Our literature review and charting of key themes identi-
fied significant discrepancy along the following areas
regarding the maternal morbidity definition: time frame,
severity, identification and classification. Our scoping
survey included questions related to these key themes,
and also assessed demographic characteristics. The results
will be presented under these key areas, summarizing the
literature review and including the feedback from the
questionnaires. There were fifty-five respondents to the
survey representing all of the WHO geographic regions
with the exception of the South-East Asia region (res-
ponse rate = 42.3%). A summary of data on the respon-
dents is provided in Table 1.
Time frame for maternal morbidity
Our literature review revealed inconsistencies regarding
the time frame within which a condition must occur to
be considered a maternal morbidity, particularly around
pre-pregnancy and postpartum. Several articles include
pre-existing conditions (prior to a pregnancy) as a maternal
morbidity if these conditions are aggravated by the preg-
nancy [18,19]. Other literature does not include the pre-
pregnancy time in their definition of maternal morbidity,
and only consider complications that arise during preg-
nancy, delivery, or the postpartum period [20].
The time frame considered relevant for a postpartum
maternal morbidity also varied. Some literature consideredTable 1 Background information on the respondents
Overall Fifty-five (N = 55) individuals respo
of respondents was split evenly be
Geographic distribution Of the 55 respondents, the distribu
(n = 8), Region of the Americas (n
South-East Asia Region (n = 0), We
Organizations represented Respondents categorized their org
institution (n = 13), a medical/heal
Work classifications Respondents described their work
and/or service delivery (n = 12), or
management (n = 8), reproductive
communication (n = 2), or other (n
Note: Respondents could select moremorbidities that occurred within 42 days after giving birth,
others included maternal problems up to 24 weeks post-
partum, and some studies even examined maternal mor-
bidities occurring anytime within the whole year after
[8,21,22]. Often the time frame was not specifically stated
or defined in literature, and time frames of “preconception”
or “postpartum” were used without defining the length
of time for those time periods. It has been indicated
that maternal morbidities can be either acute or chronic,
lasting from a range of months to years, and suggested that
an ideal source for morbidity surveillance should include
data on morbidity occurring during the entire year after
delivery [21,23].
In line with the literature, nearly all respondents (95%)
to the scoping exercise questionnaire indicated that
maternal morbidity is relevant to pregnancy, labour and
delivery, and the postpartum period. Only 36% of the
respondents indicated that maternal morbidity is relevant
to the pre-pregnancy time period. When asked whether a
maternal morbidity can include a health condition that
exists before a woman becomes pregnant (i.e. asthma,
cardiac disease, diabetes), just over half of respondents
(53%) felt that the answer is positive only if the condition
worsens, or causes difficulty during pregnancy, delivery
and postpartum.
The responses varied concerning the amount of time
postpartum within which the onset of a complication
must occur to become considered a postpartum ma-
ternal morbidity (ranging from 6 weeks to more than
1 year) and the majority of respondents selected
“6 weeks” (58%) or “1 year” (27%). It was suggested that
the time frame might depend on the specific condition
or type of complication. The responses were divided bet-
ween keeping the time frame consistent with maternal
mortality definition (42 days) and modifying the time
frame to include conditions as long as they can be linked
to the pregnancy. To accurately capture and monitor
maternal morbidities, a more cohesive viewpoint on the
time frame within which relevant complications must
occur should be established.nded with completed questionnaires (response rate = 42.3%). The sex
tween male (48%) and female (52%).
tion among the WHO geographic regions was as follows: African regions
= 13), Eastern Mediterranean Region (n =6), European Region (n = 16),
stern Pacific Region (n =2), and not reported (n = 10).
anization type as government/ministry (n = 25), an academic/research
th organization (n = 11), a United Nations agency (n = 1), other (n = 5).
as being research/evaluation (n = 13), statistics (n = 13), health/medical
teaching/training (n = 10), policymaking (n = 9), program development/
health/family planning services (n = 6), advocacy (n = 3), health
= 5).
than one option for their work.
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Our review of current literature revealed that resear-
chers have utilized maternal morbidity definitions of
varying severities that range from less severe complica-
tions of pregnancy, and extend to near miss morbidity
[19,24,25]. Maternal near miss has been defined as “a
woman who nearly died but survived a complication that
occurred during pregnancy, childbirth or within 42 days
of termination of pregnancy” [26] but it is apparent that
other, less severe, conditions are also critical when
considering maternal health. Some studies on maternal
morbidity include conditions that are potentially less
severe but a discomfort for a pregnant woman, such as
nausea, bed rest, or a car crash injury [25]. Other re-
search focused on more severe conditions, such as those
which utilize pregnancy-associated hospitalizations as an
indicator of maternal morbidity [19,27].
The majority of respondents (91%) to the scoping
exercise questionnaire felt that maternal morbidity could
be either a temporary or a permanent condition. When
asked about a range of severities that should be consid-
ered a maternal morbidity, two-thirds of respondents
(66%) said that any perinatal condition, even if it does
not require hospitalization or treatment, but may result
in discomfort or dissatisfaction for the woman (e.g.
excessive vomiting, nausea, oedema, depression) should
be considered a maternal morbidity. However, contrasting
suggestions were made that to be considered a maternal
morbidity the condition must require medical inter-
vention or treatment other than routine medication for
expected side effects. It is evident that there is not a clear
consensus among surveyed experts regarding the relevant
severities of conditions for a maternal morbidity.
About three-quarters of respondents (76%) felt that
maternal morbidity should comprise a spectrum or
continuum of severity. However it was also suggested
that the categories along the continuum must be easy
for all health workers to objectively identify for reporting
purposes. A continuum of severity has been proposed
that progresses from normal/healthy pregnancy, to mor-
bidity, to severe morbidity, to near miss, and finally to
death [28]. It was noted by the respondents that there is
no clear cut off point to distinguish between levels of
severity for maternal morbidity. However, a majority of
the respondents agreed that there should a scoring
system based on several factors such as organ system
failure, surgical intervention, extended intubation as well
as quality of life measures. While the majority of recent
research and attention has been around severe and life-
threatening maternal morbidities (i.e. near miss), the
definition of maternal morbidity should likely consist of
a spectrum of severity with thoughtful consideration of
how to distinguish cut-off points along the spectrum for
various conditions.Identification and classification of maternal morbidity
Current literature includes a wide range of methods for
identifying and classifying maternal morbidity. Maternal
morbidities have been grouped under various categories
such as direct obstetric morbidity, indirect obstetric
morbidity and psychological obstetric morbidity [29] or
obstetric complications, pre-existing medical conditions
[30,31], or categories of obstetric morbidity that occur
during pregnancy, during delivery, or after delivery [32].
Another way to categorize potentially life-threatening
maternal conditions has been by type of complication,
such as hemorrhagic complications, hypertensive disorders,
or management indicators of severity [31]. Yet another
example of the variety of categorization is the grouping of
selected obstetric complications into “non-severe condi-
tions”, “severe conditions”, and “procedures” [33].
In addition to the wide range of how maternal mor-
bidity conditions are categorized, the methodology for
detecting a maternal morbidity varied across studies as
well, including interview-based diagnosis and hospital
records (e.g. birth/hospital discharge data) [34,35]. A set
of uniform diagnostic criteria and methodology of
identification would allow for comparisons of maternal
morbidity measures across settings. Severe maternal
morbidity monitoring programs of various countries
often use different methods of defining severe acute
maternal morbidity (SAMM), including the International
Statistical Classification of Diseases (ICD) and procedure
codes, management and organ failure-based, and diagno-
sis-based criteria. For example, two key obstacles indicated
in the capacity to monitor severe maternal morbidity
in Australia have been the poor discrimination of se-
verity of disease in coding categories of ICD and the
lack of nationally agreed clinical and data definitions
for particular morbid conditions to monitor maternal
morbidity through the National Perinatal Data Collec-
tion (NPDC) [36].
Several studies identified in our literature review used
pregnancy-associated hospitalizations as a proxy for
maternal morbidity, whereas other literature argues that
this methodology would not capture the full range of
complications which might occur in the community and
not reach a facility [19,27,37]. It has been suggested that
the use of both diagnoses and procedures, and preg-
nancy and general diagnosis codes in all available fields
for the admission, increases the likelihood of identifying
morbidity in this study on measuring maternal morbidity
in routinely collected health data [38].
A challenge of determining the frequencies of severe
reproductive morbidities in high resource countries may
be due to the different types of surveillance and report-
ing among various hospitals or countries [39]. In low
resource countries, or in settings where diagnostic ser-
vices are unavailable or underutilized, many women may
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[34]. This could be due to lack of accessible services, not
easily recognizable symptoms, or the particular condition
may be so common in the community that its symptoms
are considered the norm [34].
In our questionnaire, the majority of respondents
(83%) felt that cases of maternal morbidity should be
identified by “mixed criteria” based on a combination of
clinical criteria related to a specific disease, intervention/
treatment received, organ system dysfunction-based crite-
ria, self-report, hospitalization and/or ICU admission. It
was also noted that classification should employ the
“direct, indirect, incidental” approach that is used in
classifying maternal mortality. Respondents provided their
perspectives on the challenges to measuring maternal
morbidity, including the notion that perceptions of
illness vary between cultures and the resistance that
some women have to discussing personal matters.
Such barriers and challenges should be considered
and further explored when developing a systematic meth-
odology for identification and measurement of maternal
morbidity internationally.
Demographics and maternal morbidity
Our literature review highlighted that certain demo-
graphic characteristics might place a woman at greater
risk for experiencing a maternal morbidity. In the
questionnaire, the main demographic characteristics that
respondents felt are associated with an increased risk of
a woman experiencing a maternal morbidity were age
(92%), income level (89%), geographic location (89%),
and education level (81%). The value in understanding
the relationship between demographic characteristics
and maternal morbidity is that it allows for targeted
attention and services to the populations that need
it most.
Discussion
This paper describes the findings of our scoping exercise
on maternal morbidity which included a literature
review and survey of expert opinion. Our initial litera-
ture review was performed to obtain a sense of the range
of definitions and conditions included in various studies of
maternal morbidity, paying particular attention to the
similarities and discrepancies of the definitions used across
the studies. Key areas of interest identified regarding how
maternal morbidity has been discussed in the literature
were: time frame, severity, identification and classification
and demographics. Based on the literature review findings,
a questionnaire was developed and finalized using a modi-
fied Delphi Method and it was sent to a group of selected
experts.
Overall our scoping exercise indicated that significant
discrepancy in literature and expert opinion existsconcerning the elements of a maternal morbidity defin-
ition. Therefore it also underlines the clear need for a
concrete definition that would allow for consistent
measurement and monitoring of maternal morbidity
across settings and time. It will be a challenge to estab-
lish consensus on an ideal process for identification and
classification of maternal morbidities that applies to both
high and low resource countries, given the varying avail-
ability and use of reproductive health and diagnostic ser-
vices. It should be noted that there has been significant
progress in efforts to measuring and monitoring aspects
of severe maternal morbidity such as near miss. The
WHO recently published a multi-country survey in 29
countries using the WHO maternal near miss approach
[40,41]. Furthermore, research using the WHO near miss
criteria have been conducted in different parts of sub-
Saharan Africa, suggesting that in low-resource settings
further evaluation of the tool may be needed to accurately
capture occurrence of maternal near miss [42-44]. While
this body of work focused on severe maternal morbidity
and near miss is critical, there is still a need for a more
comprehensive assessment of maternal morbidities, which
are non-severe or non-life threatening. This scoping exer-
cise and following efforts of the WHO Maternal Morbid-
ity Working Group is currently working to fill that gap.
In the questionnaire used for this scoping exercise, the
respondents favoured classifying maternal morbidities
into categories such as direct, indirect and incidental as
used for maternal mortality. However, in practice, the
interpretation of what clinical conditions should be
included in which category has been inconsistent. These
inconsistencies have compounded the difficulties in
interpreting statistics on maternal mortality and in part
led to the development of the WHO application of
ICD-10 to deaths during pregnancy, childbirth, and the
puerperium: ICD-MM [45]. The classification system
ultimately proposed by the Maternal Morbidity Working
Group will draw lessons from that endeavour and
further contribute to the 11th revision of the key stan-
dards for health conditions ICD-11 [46,47].
There are several limitations to this exercise which
should be mentioned. The literature review conducted
to inform the development of our scoping exercise
questionnaire was not a systematic review. However, a
purpose of this scoping exercise was to assist in determin-
ing what further systematic reviews related to maternal
morbidity are needed. Additionally, the response rate for
our questionnaire was under 50%, but there was represen-
tation from all but one of the WHO geographic regions.
On the other hand, the results provided valuable feedback
on identifying the gaps in knowledge and lack of consen-
sus around how maternal morbidity is defined which will
inform the next phases of work in the broader maternal
morbidity project. While the focus of this scoping exercise
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between neonatal health and the health of the mother.
Certain neonatal conditions could be related to the condi-
tion of the mother, or to other causes (e.g. medical care)
and the relationship between the monitoring of maternal
and neonatal complications is an area that warrants
further attention and study.
The results of this scoping exercise were presented at
the first Maternal Morbidity Working Group meeting
held in Geneva, Switzerland in April 2012, and helped to
direct the discussion towards achieving consensus on a
definition for maternal morbidity. Planned results of the
WHO maternal morbidity project are expected to
substantially contribute to improving maternal health
through strengthening information for global and local
decision-making in allocating resources and planning
interventions to reduce maternal morbidity. The new
definition of maternal morbidity will also be incor-
porated in the ICD-11 and related health problems,
further enhancing the sustainability of the outputs of
this effort. Only after this work is completed, can
there be reliable monitoring of progress towards
MDG 5 and beyond.
Conclusions
Current calculations of maternal morbidity rates are not
based on standard, well documented, and transparent
methodologies. Rigorous and routine measurements of
maternal morbidity are necessary to inform policy and
program decisions and resource allocations that will also
help reducing maternal deaths, and long-term suffering
and disability. Improved systems of measurement will
also allow for comparison of maternal morbidity burden
across settings within and between countries. The scop-
ing exercise highlighted that significant discrepancy in
literature and expert opinion exists concerning elements
of a maternal morbidity definition. There is a clear need
for a concrete definition that would allow for consistent
measurement and monitoring of maternal morbidity
across settings and time.Additional file
Additional file 1: Template of the Maternal Morbidity Scoping
Exercise Survey.
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